Nevertheless,
New drug against malaria gives:
Novartis obtained Swissmedic’s authorizations for his anti-paludism medication for newborns. Furthermore, young children, the first victims of the disease. Furthermore, Expectations are immense worldwide.
In Africa, three deaths out of four due to Malaria (or malaria) occur before the age of five. However, Many of them fall ill from the first weeks of life. Moreover, The disease strikes early. death is rapid if children are not treated, explains Elisabeth Reus, of the Tropical Institute and Swiss Public Health (Swiss TPH).
The Novartis pharmaceutical laboratory has received approval from the Swiss Institute for Therapeutic Products (Swissmedic) for its drug “Coartem Baby”. the first intended for newborns and young children, according to a press release published on Tuesday.
The press release also specifies that eight African countries should soon have their authorization. Novartis plans to introduce the drug in children to improve access to treatment in areas where malaria is endemic.
Coartem, an antimalarial drug, has been used successfully for years in adults and children. However. it is not effective in the smallest and lightest children: newborns, babies up to six months and malnutris children weighing less than five kilos.
In recent years. the drug has been tested with this particularly vulnerable group in several African countries, in collaboration with the non -profit organization Medicines for Malaria Venture and other institutions, with success.
Doubts over the duration of treatment efficiency – New drug against malaria gives
Novartis plans to put Coartem Baby on the market by the end of the year. new drug against malaria gives promises to provide the combined drug with low cost and on a “largely non -lucrative base”. This would make it possible to fill a major therapeutic gap, underlines Elisabeth Reus.
It remains to be hoped that the antimalarial drug for infants does not lose its effectiveness too quickly. because COARTEM contains artemisinin as an active ingredient – an active ingredient of plant origin against which the strains of malaria have already developed resistance in the last two decades.
Article original: Katharina Bochsler (SRF)
French adaptation: Julien Furrer (RTS)
Further reading: The French headquarters of Nestlé searched in the case of treated mineral waters – rts.ch – Ferrero buys WK Kellogg for $ 3.1 billion – Opinion of analysts of the day: EXAIL SUPERSTAR, Acceleration at Michelin, TFF disappoints – The 20 minutes and morning staff. – Second trimester | Economic uncertainty ruins the appetite of American group MTy customers.
